These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 12025854)

  • 21. Prescriptions imported into the United States.
    Tenn Med; 2004 Aug; 97(8):337. PubMed ID: 15376708
    [No Abstract]   [Full Text] [Related]  

  • 22. Dealing with drug advertising. The FDA can't always enforce the rules on misleading ads.
    Atkinson HG
    Health News; 2003 Feb; 9(2):5. PubMed ID: 12632541
    [No Abstract]   [Full Text] [Related]  

  • 23. Regulating drugs for effectiveness and safety: a public health perspective.
    Zito JM; Socolar SJ; Eilers R; Crystal S; Lexchin J
    Med Care; 2007 Sep; 45(9):911. PubMed ID: 17712264
    [No Abstract]   [Full Text] [Related]  

  • 24. Drug names--a semblance of order.
    Feldman EG
    J Pharm Sci; 1966 Jun; 55(6):i. PubMed ID: 5924136
    [No Abstract]   [Full Text] [Related]  

  • 25. Dying to live.
    Nat Med; 2006 Jun; 12(6):593. PubMed ID: 16760985
    [No Abstract]   [Full Text] [Related]  

  • 26. PROOF OF NEW DRUG EFFICACY.
    LEVIN M
    Mil Med; 1965 Jul; 130():695-7. PubMed ID: 14301148
    [No Abstract]   [Full Text] [Related]  

  • 27. THE PHYSICIAN AND THE FOOD AND DRUG ADMINISTRATION.
    SADUSK JF
    JAMA; 1964 Dec; 190():907-9. PubMed ID: 14214493
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmaceutical postmarket review: fact or fiction?
    Schanz SJ
    Food Drug Law J; 2007; 62(3):493-500. PubMed ID: 17915391
    [No Abstract]   [Full Text] [Related]  

  • 29. RECENT EXPERIENCES WITH EFFECTIVE NEW DRUG APPLICATIONS.
    MEYERS EL
    Bull Parenter Drug Assoc; 1964; 18():1-6. PubMed ID: 14224959
    [No Abstract]   [Full Text] [Related]  

  • 30. The FDA takes action against unapproved drugs.
    Meadows M
    FDA Consum; 2007; 41(1):34-5. PubMed ID: 17342837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The regulation of drugs and biologics: fifty years into the future.
    Kuhlik BN
    Food Drug Law J; 2000; 55(1):21-5. PubMed ID: 12269358
    [No Abstract]   [Full Text] [Related]  

  • 32. Remarks delivered at the Food and Drug Law Institute's 48th Annual Conference.
    Enzi MB
    Food Drug Law J; 2005; 60(2):103-6. PubMed ID: 16097090
    [No Abstract]   [Full Text] [Related]  

  • 33. Realizing two-tiered innovation policy through drug regulation.
    Ridgway WE
    Stanford Law Rev; 2006 Feb; 58(4):1221-50. PubMed ID: 16685807
    [No Abstract]   [Full Text] [Related]  

  • 34. A taste of new medicine.
    Nat Med; 2006 May; 12(5):481. PubMed ID: 16675969
    [No Abstract]   [Full Text] [Related]  

  • 35. Free rein for drug ads? A slowdown in FDA review has left consumers more vulnerable to misleading messages.
    Consum Rep; 2003 Feb; 68(2):33-7. PubMed ID: 12516586
    [No Abstract]   [Full Text] [Related]  

  • 36. Regulating the fate of pharmaceutical drugs: a new prescription for the environment.
    Nidel CT
    Food Drug Law J; 2003; 58(1):81-101. PubMed ID: 12739585
    [No Abstract]   [Full Text] [Related]  

  • 37. Curbing counterfeit drugs.
    FDA Consum; 2006; 40(5):11. PubMed ID: 17326307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Food and Drug Administration and patent law at a crossroads: the listing of polymorph patents as a barrier to generic drug entry.
    Srivastava D
    Food Drug Law J; 2004; 59(2):339-54. PubMed ID: 15298015
    [No Abstract]   [Full Text] [Related]  

  • 39. FDA cracks down on labeling, initiates trial result reporting.
    Osborne R; Waltz E
    Nat Biotechnol; 2008 Nov; 26(11):1203-4. PubMed ID: 18997742
    [No Abstract]   [Full Text] [Related]  

  • 40. FDA poisoning surveillance notes.
    Vet Hum Toxicol; 1990 Jun; 32(3):292-5. PubMed ID: 2191492
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.